9,033 Shares in Tenet Healthcare Co. (NYSE:THC) Acquired by Vista Investment Partners II LLC

Vista Investment Partners II LLC bought a new position in Tenet Healthcare Co. (NYSE:THC) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 9,033 shares of the company’s stock, valued at approximately $1,140,000.

A number of other hedge funds also recently bought and sold shares of the company. Daiwa Securities Group Inc. purchased a new stake in shares of Tenet Healthcare during the 4th quarter valued at about $252,000. Moran Wealth Management LLC boosted its stake in shares of Tenet Healthcare by 18.2% in the 4th quarter. Moran Wealth Management LLC now owns 2,439 shares of the company’s stock worth $308,000 after buying an additional 375 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank lifted its holdings in Tenet Healthcare by 5.4% in the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 32,370 shares of the company’s stock valued at $4,086,000 after acquiring an additional 1,656 shares during the period. Taika Capital LP bought a new stake in shares of Tenet Healthcare during the 4th quarter valued at about $498,000. Finally, Kendall Capital Management bought a new position in shares of Tenet Healthcare in the 4th quarter worth approximately $478,000. Institutional investors own 95.44% of the company’s stock.

Tenet Healthcare Trading Up 1.8 %

THC stock opened at $127.64 on Monday. Tenet Healthcare Co. has a 12 month low of $90.03 and a 12 month high of $171.20. The company has a market capitalization of $12.14 billion, a PE ratio of 3.96, a P/E/G ratio of 1.02 and a beta of 2.06. The firm’s 50-day moving average is $132.66 and its 200 day moving average is $145.89. The company has a debt-to-equity ratio of 2.25, a current ratio of 1.78 and a quick ratio of 1.70.

Tenet Healthcare (NYSE:THC) last announced its quarterly earnings results on Wednesday, February 12th. The company reported $3.44 EPS for the quarter, beating the consensus estimate of $2.95 by $0.49. Tenet Healthcare had a return on equity of 21.88% and a net margin of 15.48%. On average, research analysts anticipate that Tenet Healthcare Co. will post 12.24 EPS for the current year.

Analysts Set New Price Targets

Several research analysts have recently weighed in on the stock. Cantor Fitzgerald reiterated an “overweight” rating and set a $177.00 price target on shares of Tenet Healthcare in a research note on Thursday, February 13th. Truist Financial dropped their price target on shares of Tenet Healthcare from $190.00 to $175.00 and set a “buy” rating for the company in a research report on Monday, January 6th. TD Cowen began coverage on shares of Tenet Healthcare in a report on Wednesday, February 26th. They issued a “buy” rating and a $175.00 target price for the company. Barclays lowered their price objective on Tenet Healthcare from $190.00 to $161.00 and set an “overweight” rating on the stock in a research report on Thursday, February 13th. Finally, Raymond James downgraded Tenet Healthcare from a “strong-buy” rating to an “outperform” rating and set a $195.00 target price on the stock. in a research note on Friday, November 22nd. Four investment analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, Tenet Healthcare presently has a consensus rating of “Moderate Buy” and a consensus target price of $163.88.

Tenet Healthcare Profile

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.